Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Stonehenge Partners Llc Insider Profile
4 Followers
Stonehenge Partners Llc, Ten Percent Owner at Qualigen Therapeutics, holds 817.27K shares in Qualigen Therapeutics (Ticker: QLGN).
Stonehenge Partners Llc has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Stonehenge Partners Llc's holdings
Insider Roles
Ten Percent Owner
Roles that Stonehenge Partners Llc holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Stonehenge Partners Llc
Stonehenge Partners Llc's Trading History
List of latest transactions for each holding click on a transaction to see Stonehenge Partners Llc's performance on stock
You May Also Like
Stonehenge Partners Llc insider profile FAQ
What is the percentage of profitable transactions made by Stonehenge Partners Llc?
The percentage of profitable transactions made by Stonehenge Partners Llc is ―.
What is the average return per transaction made by Stonehenge Partners Llc?
The average return per transaction made by Stonehenge Partners Llc is ―.
What stocks does Stonehenge Partners Llc hold?
Stonehenge Partners Llc holds: QLGN stocks.
What was Stonehenge Partners Llc’s latest transaction?
Stonehenge Partners Llc latest transaction was an Uninformative Buy of ―.
What was Stonehenge Partners Llc's most profitable transaction?
Stonehenge Partners Llc’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Stonehenge Partners Llc's role in Qualigen Therapeutics?
Stonehenge Partners Llc's role in Qualigen Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.